Check this out! Our last translational ferroptosis paper from excellent PhD student. Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease | Cell Death & Differentiation #ferroptosis#MASLD https://t.co/WuyU1LFRMr
And now it's time for Camilla Scarpellini to defend the hard work she's done during her phD on the design of new ferroptosis and necroptosis inhibitors.
👏👏👏👏
#ferroptoteam@UAMCAntwerp
Today we have the pleasure to hold a Symposium on #ferroptosis at the UAntwerpen @UAMCAntwerp. It was really inspiring to listen to @Conrad_Lab, @TomVBerghe and @Raph_Frederick. Thank you for presenting the advances in the field and the great discussion that followed.
Thrilled to see our paper "Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression" online @CDD
Big kudos the first talented author @EmilyVanSan1.
#Ferroptosis#CellDeath@TomVBerghe
https://t.co/f5b8seGOLO
Super nice talk of @g_klejborowska on future ferroptosis efforts in neurodegenerative diseases! Best combo alive, I would say as a Belgian… beer and science 😉
CONGRATULATIONS, @Davide_Ceradini! The Ph.D. thesis "Development of Scalable Synthesis for Selected #SerineProtease uPA Inhibitors” was supervised by Kirill Shubin and Prof. @AiJirgensons at @osi_lv and @RTU_LV .
Check it out! 👉https://t.co/DXn5IU05aN
#H2020#InvestEUresearch
👋Our new publication on RIPK-1 inhibitor is out !
Take a look if you want to see how small pharmacomodulations allowed us to get more affinity for RIPK1 than PERK.
#Celldeath#necroptosis
cc @g_klejborowska@KoenAugustyns
I'm extremely happy to announce I have been awarded a #MSCA postdoctoral fellowship for my project DPP9-TACDrug. Exciting times starting now thanks to @MSCActions, Dr. Pieter Van Der Veken and @UAntwerpen!